Table 5 Impact of serology results on vaccination uptake in IBD cohort
From: Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease
Vaccine administered | Serology result n/da (%) | p value | ||
|---|---|---|---|---|
Non-immune or equivocal | Unknown | Total | ||
VZV | 20/36 (55.5%) | 4/7 (57.1%) | 24/43 (55.8%) | p = 0.953 |
MMR | 16/30 (53.3%) | 2/15 (13.3%) | 18/45 (40%) | p = 0.012 |
 Measles | 12/18 (33.3%) | 2/15 (13.3%) | 14/33 (42.4%) | p = 0.004 |
 Mumps | 12/15 (80%) | 2/15 (13.3%) | 14/30 (46.7%) | p = 0.001 |
 Rubella | 15/26 (57.7%) | 2/13 (13.3%) | 17/39 (43.6%) | p = 0.008 |
HBV | 26/37 (70.3%) | 2/9 (22.2%) | 28/46 (60.1%) | p = 0.018 |